Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01615835 · ClinicalTrials.gov registry record · NA
EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant
A NA study of Congestive Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 2
- Study locations
NCT01615835 is a NA study of Congestive Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 16 participants, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01615835, a NA study of Congestive Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 2
- Study locations
Study Summary
Use of the EnSite NavX system to map the coronary vasculature during CRT implant
Conditions Studied
Interventions
- OTHER EnSite NavX System
Study Locations (2)
Georgia
- Medical College of Georgia - Augusta
North Carolina
- Duke Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-04 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01615835
The ClinicalTrials.gov registry entry for NCT01615835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (95% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which EnSite NavX System is the first listed.
NCT01615835 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01615835 about?
NCT01615835 is a clinical study titled "EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant". Use of the EnSite NavX system to map the coronary vasculature during CRT implant
What is the current status of trial NCT01615835?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2007-04. Estimated completion is 2007-10.
What conditions does trial NCT01615835 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT01615835?
The interventions under investigation include: EnSite NavX System (OTHER).
Who is sponsoring clinical trial NCT01615835?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01615835 being conducted?
This trial has 2 study locations across Georgia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
SyncAV Post-Market Trial
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.